Pirfenidone Viatris Europese Unie - Nederlands - EMA (European Medicines Agency)

pirfenidone viatris

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressiva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Dapagliflozin Viatris Europese Unie - Nederlands - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - geneesmiddelen die worden gebruikt bij diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 en 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Europese Unie - Nederlands - EMA (European Medicines Agency)

clopidogrel viatris (previously clopidogrel taw pharma)

viatris limited - clopidogrelbesilaat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotische middelen - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). het st-segment elevatie acuut myocardinfarct, in combinatie met asa in medisch behandelde patiënten in aanmerking komen voor trombolytische therapie. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. voor meer informatie refereer je naar sectie 5.

AtorvastaViatris 10 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atorvastaviatris 10 mg filmomh. tabl.

viatris gx bv-srl - atorvastatinecalcium 10,844 mg - eq. atorvastatine 10 mg; macrogol 0,631 - filmomhulde tablet - 10 mg - atorvastatinecalcium 10.84 mg - atorvastatin

AtorvastaViatris 20 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atorvastaviatris 20 mg filmomh. tabl.

viatris gx bv-srl - atorvastatinecalciumtrihydraat 21,688 mg - eq. atorvastatine 20 mg - filmomhulde tablet - 20 mg - atorvastatinecalcium 21.69 mg - atorvastatin

AtorvastaViatris 40 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atorvastaviatris 40 mg filmomh. tabl.

viatris gx bv-srl - atorvastatinecalciumtrihydraat 43,376 mg - eq. atorvastatine 40 mg - filmomhulde tablet - 40 mg - atorvastatinecalcium 43.38 mg - atorvastatin

AtorvastaViatris 80 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atorvastaviatris 80 mg filmomh. tabl.

viatris gx bv-srl - atorvastatinecalciumtrihydraat 86,751 mg - eq. atorvastatine 80 mg - filmomhulde tablet - 80 mg - atorvastatinecalcium 86.75 mg - atorvastatin

Viatrisatorvastigen 20 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatrisatorvastigen 20 mg filmomh. tabl.

viatris gx bv-srl - atorvastatinecalciumtrihydraat 21,688 mg - eq. atorvastatine 20 mg - filmomhulde tablet - 20 mg - atorvastatinecalcium 20.72 mg - atorvastatin

Viatrisatorvastigen 40 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatrisatorvastigen 40 mg filmomh. tabl.

viatris gx bv-srl - atorvastatinecalciumtrihydraat 43,376 mg - eq. atorvastatine 40 mg - filmomhulde tablet - 40 mg - atorvastatinecalcium 41.44 mg - atorvastatin

Viatrisatorvastigen 80 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatrisatorvastigen 80 mg filmomh. tabl.

viatris gx bv-srl - atorvastatinecalciumtrihydraat 86,751 mg - eq. atorvastatine 80 mg - filmomhulde tablet - 80 mg - atorvastatinecalcium 82.88 mg - atorvastatin